Re-Vana Therapeutics Completes of $3.25MM Pre-Series A Financing

Re-Vana Completes $3.25MM Pre-Series A Financing led by Visionary Ventures and ExSight Ventures to Support Pre-clinical Development of Sustained Release Biologic and Small Molecule Therapeutics.

Click here to view the press release